Clinical Investigation of the Visual Outcomes and Safety of a Trifocal Toric IOL in an Asian Population

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

December 17, 2021

Study Completion Date

December 17, 2021

Conditions
AphakiaCorneal Astigmatism
Interventions
DEVICE

ACRYSOF® IQ PanOptix® Toric Trifocal IOL

Single-piece, ultraviolet and blue-light filtering, foldable, multifocal toric IOL intended to provide vision to aphakic subjects at near, intermediate, and distance and to correct pre-existing corneal astigmatism. This device is approved in Australia.

PROCEDURE

Cataract surgery

Cataract extraction by phacoemulsification, followed by implantation of the IOL per investigator's standard of care and instructions for use

Trial Locations (4)

2150

Alcon Investigator 7678, Sydney

2194

Alcon Investigator 8117, Campsie

3011

Alcon Investigator 7813, Footscray

3021

Alcon Investigator 8122, Saint Albans

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY